Sysmex (OTCMKTS:SSMXY) Sees Strong Trading Volume – Here’s What Happened

Sysmex Corporation ADR (OTCMKTS:SSMXY – Get Free Report) saw strong trading volume on Monday. Approximately 798,287 shares changed hands during trading, an increase of 289% from the previous session’s volume of 205,006 shares. The stock last traded at $11.5650 and had previously closed at $11.60.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Sysmex from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 18th. Two investment analysts have rated the stock with a Hold rating. According to MarketBeat, the company has a consensus rating of “Hold”.

Read Our Latest Stock Analysis on SSMXY

Sysmex Trading Down 2.1%

The firm has a market capitalization of $6.95 billion, a PE ratio of 27.19 and a beta of 1.18. The company’s 50-day simple moving average is $11.93 and its 200 day simple moving average is $10.07. The company has a quick ratio of 2.53, a current ratio of 3.40 and a debt-to-equity ratio of 0.23.

Sysmex (OTCMKTS:SSMXY – Get Free Report) last issued its quarterly earnings data on Friday, August 7th. The company reported $0.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.07 by $0.02. The firm had revenue of $825.85 million for the quarter, compared to the consensus estimate of $741.67 million. Sysmex had a net margin of 7.62% and a return on equity of 8.01%. Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. As a group, sell-side analysts expect that Sysmex Corporation ADR will post 0.41 EPS for the current year.

Sysmex Company Profile

(Get Free Report)

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and distributes in vitro diagnostic products and laboratory solutions. The company is best known for its automated hematology analyzers, which are used to examine blood cells, along with related reagents, software and support services.

Its product portfolio also includes systems for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory automation and information-management solutions.

See Also

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.